Suzhou Zelgen Biopharmaceuticals Co.,ltd

This study tests an experimental pill called jaktinib for adults with moderate to severe atopic dermatitis (eczema). About 443 participants will receive either the drug or a placebo to see if it improves skin symptoms like redness and itching. The goal is to find a new treatment …

This study tests a new drug called ZG005 in 50 adults with advanced solid tumors that did not respond to or could not tolerate standard treatments. The main goal is to see if the drug shrinks tumors and to check for side effects. Participants receive the drug and are monitored cl…

This study tests a new drug called jaktinib for people with active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. About 265 adults will receive either jaktinib or a placebo to see if the drug improves pain and function after 16 weeks. The goal is…